Literature DB >> 18788850

Pulmonary and cardiovascular complications of obesity: an autopsy study of 76 obese subjects.

Abida K Haque1, Swarupa Gadre, Jerrod Taylor, Sajid A Haque, Daniel Freeman, Alex Duarte.   

Abstract

CONTEXT: Obesity is associated with sleep disordered breathing and cardiovascular morbidity, but the relationship between pulmonary hypertension, heart disease, and obesity is unknown.
OBJECTIVE: To determine the prevalence of pulmonary and cardiovascular disease in obese subjects undergoing autopsy at a large medical center.
DESIGN: A search through autopsy records from an 11-year period identified 76 subjects with a body mass index greater than 30 kg/m(2) and 46 age-matched, nonobese controls. Clinical data were collected from medical charts and autopsy records. Formalin-fixed, paraffin-embedded sections of lungs and heart were reviewed for each subject. The presence of pulmonary edema, hemorrhage, diffuse alveolar damage, thrombi, and pulmonary hypertensive changes, including intimal fibrosis, medial hypertrophy, muscularization of arterioles, alveolar capillary hemangiomatosis, hemosiderosis, and iron encrustation were documented. Hearts were examined for the presence of cardiomegaly, ventricular hypertrophy, coronary artery atherosclerosis, acute infarction, fibrosis, and inflammation. Differences between the obese and control groups were compared using a statistical software program.
RESULTS: The obese group demonstrated a greater occurrence of diabetes mellitus, systemic hypertension, pulmonary edema, hemorrhage, and pulmonary hypertensive changes compared with the control group. Alveolar capillary hemangiomatosis was exclusively observed in the obese subjects. Cardiomegaly and left ventricular hypertrophy were present in all obese subjects; approximately one third of the obese subjects had no coronary atherosclerosis.
CONCLUSIONS: Pulmonary hypertensive changes, including venous hypertension and capillary hemangiomatosis, were observed in 72% of obese subjects. Cardiomegaly with biventricular hypertrophy was present in all obese subjects and was suggestive of obesity cardiomyopathy.

Entities:  

Mesh:

Year:  2008        PMID: 18788850     DOI: 10.5858/2008-132-1397-PACCOO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  24 in total

1.  Is obesity a prognostic factor for acute myeloid leukemia outcome?

Authors:  Hun Ju Lee; Andrea S Licht; Andrew J Hyland; Laurie A Ford; Sheila N J Sait; Annemarie W Block; Maurice Barcos; Maria R Baer; Eunice S Wang; Meir Wetzler
Journal:  Ann Hematol       Date:  2011-09-21       Impact factor: 3.673

2.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

3.  Pericardial fat is associated with impaired lung function and a restrictive lung pattern in adults: the Jackson Heart Study.

Authors:  DeMarc A Hickson; Jiankang Liu; Aurelian Bidulescu; Cecil M Burchfiel; Herman A Taylor; Marcy F Petrini
Journal:  Chest       Date:  2011-07-07       Impact factor: 9.410

4.  Impact of Body Mass Index on Left Ventricular Function.

Authors:  D S Chadha; A Swamy; S K Malani; R K Ganjoo; O P Mathew
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity.

Authors:  Eric E Kelley; Jeff Baust; Gustavo Bonacci; Franca Golin-Bisello; Jason E Devlin; Claudette M St Croix; Simon C Watkins; Sonia Gor; Nadiezhda Cantu-Medellin; Eric R Weidert; Jefferson C Frisbee; Mark T Gladwin; Hunter C Champion; Bruce A Freeman; Nicholas K H Khoo
Journal:  Cardiovasc Res       Date:  2014-01-02       Impact factor: 10.787

6.  Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.

Authors:  M Weng; D M Baron; K D Bloch; A D Luster; J J Lee; B D Medoff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-09       Impact factor: 5.464

7.  Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia.

Authors:  David C Irwin; Chrystelle V Garat; Joseph T Crossno; Paul S MacLean; Timothy M Sullivan; Paul F Erickson; Matthew R Jackman; Julie W Harral; Jane E B Reusch; Dwight J Klemm
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

Review 8.  School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.

Authors:  Maureen Dobbins; Heather Husson; Kara DeCorby; Rebecca L LaRocca
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

9.  Obesity hypoventilation syndrome.

Authors:  Laila Al Dabal; Ahmed S Bahammam
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

10.  Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling.

Authors:  Benjamin D Medoff; Yoshihisa Okamoto; Patricio Leyton; Meiqian Weng; Barry P Sandall; Michael J Raher; Shinji Kihara; Kenneth D Bloch; Peter Libby; Andrew D Luster
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-23       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.